Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches

Completed · Not applicable · Has a placebo group

Conditions studied: Migraine

In brief

Cranial electrotherapy stimulation (CES) may be a safe adjunct to medical treatment for pain relief in migraine patients. However, despite the number of CES studies done, many have been open label, single blinded, or have utilized a small group of patients.

Key facts

Study ID

NCT01265797

Run by

University of Toledo Health Science Campus

People needed

68

Starts

2011-12-01

Expected to finish

2013-07-01

Last updated by the study team

2015-02-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects satisfying the IHS (International Headache Society) criteria for migraine
• Subjects have not achieved satisfactory pain control on their current medication
• Ability to maintain a daily headache diary
• Stable medication use related to migraine for at least 4 weeks prior to enrollment in the study

You may not qualify if…

• Previous exposure to or experience with cranial electrotherapy stimulation (CES)
• Contraindications to Fisher Wallace stimulator, such as cardiac pacemakers or implantable defibrillators, known or suspected heart disease, or pregnancy
• Seizure disorders

Where it is running

• University of Toledo, Health Science Campus — Toledo, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.